Mounjaro (terzepatide) and Ozempic (semaglutide) are injectable medications with FDA approval that help lower blood sugar in people with type 2 diabetes. Ozempic is also approved to lower the risk of heart complications like heart attack and stroke among people with type 2 diabetes and heart disease.